We are live on ! Find out more
RWJF

Robert Wood Johnson Foundation Portfolio holdings

AUM $125M
1-Year Est. Return 15.63%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+15.63%
3 Year Est. Return
+22.87%
5 Year Est. Return
+15.87%
10 Year Est. Return
+24.67%
AUM
$6.88M
AUM Growth
-$3.19B
Cap. Flow
+$212M
Cap. Flow %
3,081.7%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$197M
2
OBDC icon
Blue Owl Capital
OBDC
+$15.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 54.63%
2 Financials 45.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBDC icon
1
Blue Owl Capital
OBDC
$5.3B
$3.12M 45.37%
2,530,929
+1,235,627
+95% +$15.3M
RPRX icon
2
Royalty Pharma
RPRX
$26.2B
$1.93M 28.05%
+3,973,800
New +$197M
JNJ icon
3
Johnson & Johnson
JNJ
$623B
$1.83M 26.58%
13,000,000

Similar funds

Robert Wood Johnson Foundation's Q2 2020 Portfolio in Review

As of Q2 2020, Robert Wood Johnson Foundation held 3 positions worth $6.88M, down 100% from $3.2B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Robert Wood Johnson Foundation deployed $212M of net new capital in Q2 2020, opening 1 new position and adding to 1 existing holding. Its largest new stake was Royalty Pharma: 3,973,800 shares worth $1.93M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 53% a quarter earlier, followed by Financials.

  • Robert Wood Johnson Foundation's largest Q2 2020 buy was Royalty Pharma: 3,973,800 shares worth $1.93M.
  • Robert Wood Johnson Foundation added most to Blue Owl Capital in Q2 2020, an estimated $15.3M increase.
  • Robert Wood Johnson Foundation's ten largest holdings make up 100% of its $6.88M portfolio in Q2 2020.
  • Robert Wood Johnson Foundation opened 1 new position and closed 0 in Q2 2020.
  • Robert Wood Johnson Foundation's portfolio value fell 100% quarter-over-quarter to $6.88M.

Based on Robert Wood Johnson Foundation's 13F filing for Q2 2020, filed 6 Aug 2020.